Accendra Health (ACH) EBITDA Margin (2009 - 2026)
Accendra Health (ACH) reported EBITDA Margin of 7.33% for Q1 2026, down 31.0% year-over-year from 10.62% in Q1 2025, and up 1339.86% quarter-over-quarter from 0.51% in Q4 2025.
Accendra Health (ACH) EBITDA Margin (2009 - 2026) Analysis & Trends
Accendra Health (ACH) has 18 years of EBITDA Margin data on file, last reported at 7.33% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 7.33%, down 31.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.68% (up 658.0% YoY), and the FY2025 annual result was 3.82%, up 721.0% from the prior year.
- EBITDA Margin grew to 7.33% in Q1 2026 per ACH's latest filing, from 0.51% in the prior quarter.
- Over five years, EBITDA Margin peaked at 9.08% in Q3 2024 and troughed at 34.71% in Q4 2024.
- A 5-year average of 0.62% and a median of 0.92% in 2023 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin plunged 3298 bps in 2024, then surged 3522 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 2.1% in 2022, then rose by 17 bps to 1.73% in 2023, then slumped by 1905 bps to 34.71% in 2024, then soared by 101 bps to 0.51% in 2025, then soared by 1340 bps to 7.33% in 2026.
- Business Quant data shows ACH's EBITDA Margin at 7.33% in Q1 2026, 0.51% in Q4 2025, and 8.34% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.23% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.63% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 0.84% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 5.40% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 7.33% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -41.35% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.59% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -17.29% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.33% |
| Dec 31, 2025 | 0.51% |
| Sep 30, 2025 | 8.34% |
| Jun 30, 2025 | -1.15% |
| Mar 31, 2025 | 7.64% |
| Dec 31, 2024 | -34.71% |
| Sep 30, 2024 | 9.08% |
| Jun 30, 2024 | 7.35% |
| Mar 31, 2024 | 0.37% |
| Dec 31, 2023 | -1.73% |
| Sep 30, 2023 | 0.92% |
| Jun 30, 2023 | 0.42% |
| Mar 31, 2023 | 0.39% |
| Dec 31, 2022 | -2.10% |
| Sep 30, 2022 | 2.41% |
| Jun 30, 2022 | 3.00% |
| Mar 31, 2022 | 2.54% |
| Dec 31, 2021 | 2.51% |
| Sep 30, 2021 | 2.51% |
| Jun 30, 2021 | 3.89% |